Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment

Arthritis and Rheumatology

Volumn 68, Issue 2, 2016, Pages 556-

  De Velasco, Guillermo ^a   Bermas, Boonie ^b   Choueiri, Toni K ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; NIVOLUMAB; PDCD1 PROTEIN, HUMAN; PROGRAMMED DEATH 1 RECEPTOR;

ANTAGONISTS AND INHIBITORS; ARTHRITIS; AUTOIMMUNE DISEASE; CARCINOMA, RENAL CELL; CASE REPORT; CHEMICALLY INDUCED; HAND JOINT; HUMAN; KIDNEY NEOPLASMS; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; UVEITIS;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ARTHRITIS; AUTOIMMUNE DISEASES; CARCINOMA, RENAL CELL; HAND JOINTS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGRAMMED CELL DEATH 1 RECEPTOR; UVEITIS;

EID: 84956836603     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39406     Document Type: Letter

References (3)

1. Dulos J, Carven GJ, van Boxtel SJ, Evers S, Driessen-Engels LJ, Hobo W, et al., PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer. J Immunother 2012; 35: 169-78.
2. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, et al., TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007; 13: 711-8.
3. Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, et al., Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther 2010; 12: R53.